Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel

    Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel

    FromInvesting With IBD

    Start listeningView podcast show

    Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel

    FromInvesting With IBD

    ratings:
    Length:
    52 minutes
    Released:
    May 30, 2019
    Format:
    Podcast episode

    Description

    This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast.
    Released:
    May 30, 2019
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to Investing With IBD, a weekly podcast for investors who want to sharpen their trading skills, learn how to make more money and take control over their investment success. From insights into stock market trends, timeless investing tips and fundamental and technical analysis of top stocks using stock charts, this is where you’ll find the expert guidance you need to maximize your gains and minimize your losses. New episode every Thursday.